AARD—Aardvark Therapeutics IncEarnings
NASDAQ·HealthcareData sourced from Finnhub (quotes, earnings calendar, news) and Yahoo Finance (daily closing prices). Source evidence retrieved Nov 17, 2026 08:00 UTC. No upcoming date available. Read the methodology.
AARD delayed price change and context
AARD (Aardvark Therapeutics Inc) — the delayed price is temporarily unavailable. No price move or cause is inferred.
Delayed quote
Loading…
Company overview
- Sector
- Healthcare
- Industry
- Pharmaceuticals
- Exchange
- NASDAQ
- Market cap
- $0.0B
- Report time
- —
Aardvark Therapeutics Inc is listed on NASDAQ in the healthcare sector. No upcoming earnings date is currently scheduled.
Price history
Loading…
Aardvark Therapeutics Inc earnings results · Q3 2026
Reported Nov 13, 2026EPS estimate
$-0.74
EPS actual
$-0.88
Surprise
-19.1%
Price move
-12.5%
Close Nov 12 ($1.52) → close Nov 13 ($1.33) · end-of-day prices
What AARD’s latest earnings results show
Aardvark Therapeutics Inc reported EPS of $-0.88 for Q3 2026. This was $0.14 below the $-0.74 consensus estimate. An EPS beat alone does not establish revenue growth, stronger guidance or an attractive valuation.
Source: Finnhub reported EPS and consensus estimates. Fiscal quarter-end dates are not announcement dates. Price reactions use daily closes, not intraday returns.
Recent posts · AARD
All postsNo blog posts covering AARD yet.
AI Stock Analysis is a Pro feature
Get an AI-generated breakdown of every earnings setup — beat history, EPS trend, and what to watch into the print.
Unlock with ProEarnings history · EPS estimate vs actual
Last 1 quarters · Free preview · Source: Finnhub
| Quarter | Fiscal period end | Reported | EPS Est. | EPS Actual | Surprise |
|---|---|---|---|---|---|
| Q3 '26 | 2026-09-30 | 2026-11-13FinnhubRetrieved 2026-11-17 08:00 UTC | -0.74 | -0.88 | -19.1% |
Post-earnings price reaction · last 4 quarters
1-day = close after announcement vs close before. 5-day = close 5 trading days after vs close before. Projection extrapolates average magnitude.
AI summary · latest 8-K earnings release
Generated from the latest SEC EDGAR filing
Summarizing 8-K release… first run can take 10–20s.
Catalyst timeline
Upcoming and recent market-moving events for AARD · plus key macro context
Surprise prints repriced rate-cut odds last 3 of 4 releases. Bond yields and rate-sensitive sectors most exposed.
Highest-impact macro print of the cycle. SPX implied move 1.4%, semis 2.3%.
Latest news · AARD
Headlines from the past 14 days · Source: Finnhub
AARD discussion
AARD earnings FAQ
- When does AARD report earnings?
- Aardvark Therapeutics Inc (AARD) has no upcoming provider date available here. This does not mean the company has not announced one.
- What time does AARD report earnings?
- AARD historically reports during quarterly earnings season. Check the calendar for the confirmed BMO or AMC time for the next print.
- What exchange is AARD listed on?
- Aardvark Therapeutics Inc (AARD) trades on the NASDAQ in the Healthcare sector.
- How can I track AARD earnings history?
- The latest two reported quarters are publicly available. Pro subscribers can access up to eight quarters and deeper analysis.
What to listen for on the AARD earnings call
Sector- and ticker-specific items active traders track on Aardvark Therapeutics Inc's quarterly call — beyond the headline EPS and revenue beat.
- Drug / device segment revenue and pricing
- Pipeline read-outs and FDA milestones
- Medical-loss ratio (for payers)
- Updated full-year guidance range
AARD peer context
How AARD compares to other large healthcare names on the calendar.
| Ticker | Company | Exchange | Sector |
|---|---|---|---|
AARD AARD | Aardvark Therapeutics Inc | NASDAQ | Healthcare |
AAPG AAPG | Ascentage Pharma Group International American Depository Shares | NASDAQ | Healthcare |
ABBV ABBV | AbbVie Inc | NYSE | Healthcare |
ABCL ABCL | AbCellera Biologics Inc. Common Shares | NASDAQ | Healthcare |
ABEO ABEO | Abeona Therapeutics Inc | NASDAQ | Healthcare |
More Healthcare earnings
Related companies in the Healthcare sector
About AARD earnings
Aardvark Therapeutics Inc (AARD) is a healthcare company listed on the NASDAQ. No next release date is available here. . Earnings Compass tracks the report time, analyst EPS and revenue consensus, and the post-release price reaction so active traders can size positions and set alerts ahead of the print.
On reporting day, the two numbers that move AARD most are the headline EPS and the forward guidance. EPS (earnings per share) measures profit per outstanding share; a beat of analyst consensus often triggers price-target upgrades, while a miss can wipe out months of gains in a single session. The forward guidance management issues for the next quarter frequently overrides the headline — a beat-and-guide-down quarter still sells off, and a miss with a stronger outlook can rally. Active traders also watch the whisper number — the unofficial bar AARD actually has to clear for the stock to rally on the print.
For a step-by-step playbook on parsing the release, see our guides on reading an earnings report and trading earnings season. If you're new to the calendar workflow, the earnings calendar guide covers how to filter the day's reports by sector and market cap to surface the names that actually move your book.
Add AARD to your watchlist to receive an alert when the date is confirmed and again when results hit. You can also browse the full Healthcare sector page for the rest of the upcoming reports in this group, or the full earnings calendar for everything reporting this week.